ConductScience.org, home

Paper36644397

ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe.

Heyza JR and 17 others. NAR Cancer, 2023. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe. Papers, record 36644397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36644397

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe.
PubMed
Journal
NAR Cancer
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.95
iCite
Revised in PubMed
2026-02-22
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heyza JRJoshua R
2Ekinci EElmira
3Lindquist JJacob
4Lei WWen
5Yunker CChristopher
6Vinothkumar VVilvanathan
7Rowbotham RRachelle
8Polin LLisa
9Snider NGNatalie Ghttps://orcid.org/0000-0002-8693-5354
10Van Buren EEric
11Watza DDonovan
12Back JBJessica B
13Chen WWei
14Mamdani HHirva
15Schwartz AGAnn G
16Turchi JJJohn Jhttps://orcid.org/0000-0001-5375-2992
17Bepler GGerold
18Patrick SMSteve Mhttps://orcid.org/0000-0003-3325-6750

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA229535NCI NIH HHSUnited StatesR01CA229535PubMed and NIHNIH RePORTER
R01 CA141769NCI NIH HHSUnited StatesR01CA141769PubMed and NIHNIH RePORTER
R50 CA251068NCI NIH HHSUnited StatesR50CA251068PubMedNIH RePORTER
R01 CA180710NCI NIH HHSUnited StatesR01CA180710PubMedNIH RePORTER
T32 CA009531NCI NIH HHSUnited StatesT32CA009531PubMed and NIHNIH RePORTER
P30 CA022453NCI NIH HHSUnited StatesP30CA022453PubMed and NIHNIH RePORTER

Download CSV of grants

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121716293Diverse system stresses: common mechanisms of chromosome fragmentation.Cell Death Dis2011https://conductscience.org/library/papers/21716293PubMed
212003190Preclinical efficacy evaluations of XK-469: dose schedule, route and cross-resistance behavior in tumor bearing mice.Invest New Drugs2002https://conductscience.org/library/papers/12003190PubMed
331506018A consensus set of genetic vulnerabilities to ATR inhibition.Open Biol2019https://conductscience.org/library/papers/31506018PubMed
421750204Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC.Clin Cancer Res2011https://conductscience.org/library/papers/21750204PubMed
512114432Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.Clin Cancer Res2002https://conductscience.org/library/papers/12114432PubMed
628759889Mitotic progression following DNA damage enables pattern recognition within micronuclei.Nature2017https://conductscience.org/library/papers/28759889PubMed
727650543Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells.Oncotarget2016https://conductscience.org/library/papers/27650543PubMed
831529615Premature mitotic entry induced by ATR inhibition potentiates olaparib inhibition-mediated genomic instability, inflammatory signaling, and cytotoxicity in BRCA2-deficient cancer cells.Mol Oncol2019https://conductscience.org/library/papers/31529615PubMed
929252124Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors.J Clin Oncol2018https://conductscience.org/library/papers/29252124PubMed
1011481475ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11481475PubMed
1121963239BRCA1 is required for postreplication repair after UV-induced DNA damage.Mol Cell2011https://conductscience.org/library/papers/21963239PubMed
129440758ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.J Clin Oncol1998https://conductscience.org/library/papers/9440758PubMed
1335251993In Vivo Targeting Replication Protein A for Cancer Therapy.Front Oncol2022https://conductscience.org/library/papers/35251993PubMed
1427893326Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET).J Clin Oncol2017https://conductscience.org/library/papers/27893326PubMed
152393858Antitumor efficacy of interleukin-2 alone and in combination with adriamycin and dacarbazine in murine solid tumor systems.Cancer Res1990https://conductscience.org/library/papers/2393858PubMed
1627997828A Mechanism for Controlled Breakage of Under-replicated Chromosomes during Mitosis.Dev Cell2016https://conductscience.org/library/papers/27997828PubMed
1730139873An intrinsic S/G2 checkpoint enforced by ATR.Science2018https://conductscience.org/library/papers/30139873PubMed
1830538112Identification and Characterization of Synthetic Viability with ERCC1 Deficiency in Response to Interstrand Crosslinks in Lung Cancer.Clin Cancer Res2019https://conductscience.org/library/papers/30538112PubMed
1924267891ATR prohibits replication catastrophe by preventing global exhaustion of RPA.Cell2013https://conductscience.org/library/papers/24267891PubMed
2025965342A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments.PLoS One2015https://conductscience.org/library/papers/25965342PubMed

See all 39 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42773173Replication stress in cancer: origins, consequences and therapeutic opportunities.Nat Rev Cancer2026https://conductscience.org/library/papers/42773173PubMed
42755018PD-L1 in Ovarian Cancer: Immune Evasion, Tumor-Intrinsic Signaling, and Chemoresistance.Cancer Med2026https://conductscience.org/library/papers/42755018PubMed
42049240Replication protein A protects lagging strand gaps, restricting PARP inhibitor-induced synthetic lethality in BRCA1-deficient tumors.Nucleic Acids Res2026https://conductscience.org/library/papers/42049240PubMed
41973002ATR and PKMYT1 Inhibition Resensitizes a Subset of TNBC Patient-Derived Models to Carboplatin, Inducing Mitotic Catastrophe.Cancer Res Commun2026https://conductscience.org/library/papers/41973002PubMed
41166929Drug-tolerant persister cells in head and neck squamous cell carcinoma: Molecular mechanisms and therapeutic opportunities.Transl Oncol2026https://conductscience.org/library/papers/41166929PubMed
38630271When DNA-damage responses meet innate and adaptive immunity.Cell Mol Life Sci2024https://conductscience.org/library/papers/38630271PubMed
38466804The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs.Mol Cancer Ther2024https://conductscience.org/library/papers/38466804PubMed
37633920The DDUP protein encoded by the DNA damage-induced CTBP1-DT lncRNA confers cisplatin resistance in ovarian cancer.Cell Death Dis2023https://conductscience.org/library/papers/37633920PubMed

Download CSV of cited by

Genes25

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANXA5308PubTator's text mininghttps://conductscience.org/library/genes/308NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
ATR545PubTator's text mininghttps://conductscience.org/library/genes/545NCBI Gene
ATRIP84126PubTator's text mininghttps://conductscience.org/library/genes/84126NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
CCL56352PubTator's text mininghttps://conductscience.org/library/genes/6352NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CDC78317PubTator's text mininghttps://conductscience.org/library/genes/8317NCBI Gene
CDK21017PubTator's text mininghttps://conductscience.org/library/genes/1017NCBI Gene
CDKN2A1029PubTator's text mininghttps://conductscience.org/library/genes/1029NCBI Gene
CGAS115004PubTator's text mininghttps://conductscience.org/library/genes/115004NCBI Gene
CHEK11111PubTator's text mininghttps://conductscience.org/library/genes/1111NCBI Gene
COL11A21302PubTator's text mininghttps://conductscience.org/library/genes/1302NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
DBF410926PubTator's text mininghttps://conductscience.org/library/genes/10926NCBI Gene
ERCC12067PubTator's text mininghttps://conductscience.org/library/genes/2067NCBI Gene
ERCC42072PubTator's text mininghttps://conductscience.org/library/genes/2072NCBI Gene
GLB12720PubTator's text mininghttps://conductscience.org/library/genes/2720NCBI Gene
MRE114361PubTator's text mininghttps://conductscience.org/library/genes/4361NCBI Gene

See all 25 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36644397

GET https://conductscience.org/api/papers/v1/36644397/references?page=2